ARTICLE | Company News
University of South Florida, Agilis Biotherapeutics deal
October 12, 2015 7:00 AM UTC
The university granted Agilis exclusive, worldwide rights to develop and commercialize Reelin (RELN) replacement technologies to treat cognitive disorders. Agilis will provide research funding to the...